Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

Bullboard Posts

Comment by Moonshiner592on Mar 31, 2020 2:02pm

70 Views

Post# 30865116

RE:RE:I’m out... I see too many dumps at 1.5 cents!

Moonshiner592 wrote:

ETalien wrote: Good luck to longs.. I've been in KLY for so long only to go through this unknown with KLY. I'm out of sorts... again good luck!

If you've been with KLY "for so long" I'd wait untill end of month before making the call to jump ship ... there's more news coming - the stock is being artificially manipulated for a reason ...

*** sorry - end of NEXT month